Caxton Associates (UK)’s Solventum SOLV Stock Holding History

Caxton Associates (UK)’s Portfolio SOLV Stock Details SOLV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-50,000	Closed	-$3.8M	–	959
2025 Q1	$3.8M	Buy	+50,000	New	+$3.72M	0.13%	63

Other funds holding SOLV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

IFP

Independent Franchise Partners London, United Kingdom $14.3B AUM 3.49% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TFM

Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

Caxton Associates (UK)'s SOLV Position: Q2 2025 in Review

Caxton Associates (UK) sold out of Solventum (SOLV) in Q2 2025, closing a stake of 50,000 shares — an estimated $3.8M sold.

Caxton Associates (UK) first reported a position in SOLV in Q1 2025 and held it in 1 quarter. The position peaked at $3.8M in Q1 2025. 888 funds tracked by Wall St. Rank hold SOLV as of Q2 2025.

Caxton Associates (UK) reported no remaining Solventum position as of Q2 2025 after selling out during the quarter.
Caxton Associates (UK) sold 50,000 Solventum shares in Q2 2025, an estimated $3.8M.
Caxton Associates (UK) first reported a position in Solventum in Q1 2025 and held it in 1 quarter.
Caxton Associates (UK)'s Solventum position peaked at $3.8M in Q1 2025.
888 funds tracked by Wall St. Rank held Solventum as of Q2 2025.

Based on Caxton Associates (UK)'s 13F filing for Q2 2025, filed 15 Aug 2025.